Baird Maintains Neutral on Definitive Healthcare, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Vikram Kesavabhotla maintains a Neutral rating on Definitive Healthcare (NASDAQ:DH) but lowers the price target from $8 to $6.
July 31, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Baird analyst Vikram Kesavabhotla maintains a Neutral rating on Definitive Healthcare (NASDAQ:DH) and lowers the price target from $8 to $6.
The lowered price target from $8 to $6 suggests a negative outlook on the stock's performance, which could lead to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100